172 related articles for article (PubMed ID: 25572678)
1. Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma.
Lu N; Lin T; Wang L; Qi M; Liu Z; Dong H; Zhang X; Zhai C; Wang Y; Liu L; Xiang L; Qi L; Han B; Li J
Tumour Biol; 2015 May; 36(5):3843-52. PubMed ID: 25572678
[TBL] [Abstract][Full Text] [Related]
2. p53/miR-30a-5p/ SOX4 feedback loop mediates cellular proliferation, apoptosis, and migration of non-small-cell lung cancer.
Quan X; Li X; Yin Z; Ren Y; Zhou B
J Cell Physiol; 2019 Dec; 234(12):22884-22895. PubMed ID: 31124131
[TBL] [Abstract][Full Text] [Related]
3. miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4.
Li X; Jiao M; Hu J; Qi M; Zhang J; Zhao M; Liu H; Xiong X; Dong X; Han B
Prostate; 2020 Jun; 80(9):674-686. PubMed ID: 32294305
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
6. The overexpression of miR-30a affects cell proliferation of chondrosarcoma via targeting Runx2.
Jiang D; Zheng X; Shan W; Shan Y
Tumour Biol; 2016 May; 37(5):5933-40. PubMed ID: 26596830
[TBL] [Abstract][Full Text] [Related]
7. SOX4 is activated by C-MYC in prostate cancer.
Dong H; Hu J; Wang L; Qi M; Lu N; Tan X; Yang M; Bai X; Zhan X; Han B
Med Oncol; 2019 Sep; 36(11):92. PubMed ID: 31560094
[TBL] [Abstract][Full Text] [Related]
8. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro.
Wang L; Zhang J; Yang X; Chang YW; Qi M; Zhou Z; Zhang J; Han B
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):301-7. PubMed ID: 23917306
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4.
Tang T; Huan L; Zhang S; Zhou H; Gu L; Chen X; Zhang L
Oncol Rep; 2017 Oct; 38(4):2243-2250. PubMed ID: 28791372
[TBL] [Abstract][Full Text] [Related]
10. The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression.
Liu H; Wu Z; Zhou H; Cai W; Li X; Hu J; Gao L; Feng T; Wang L; Peng X; Qi M; Liu L; Han B
Neoplasia; 2019 Aug; 21(8):765-776. PubMed ID: 31238254
[TBL] [Abstract][Full Text] [Related]
11. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
Song GD; Sun Y; Shen H; Li W
Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
[TBL] [Abstract][Full Text] [Related]
12. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades.
Zhao G; Yin Y; Zhao B
J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607
[TBL] [Abstract][Full Text] [Related]
13. miR-363-3p Inhibits Osteosarcoma Cell Proliferation and Invasion via Targeting SOX4.
Wang K; Yan L; Lu F
Oncol Res; 2019 Feb; 27(2):157-163. PubMed ID: 29471893
[TBL] [Abstract][Full Text] [Related]
14. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of Sox4.
Luo XJ; Tang DG; Gao TL; Zhang YL; Wang M; Quan ZX; Chen J
Cell Physiol Biochem; 2014; 34(6):2180-8. PubMed ID: 25562164
[TBL] [Abstract][Full Text] [Related]
16. SOX4 is associated with poor prognosis in cholangiocarcinoma.
Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
[TBL] [Abstract][Full Text] [Related]
17. miR‑188 suppresses tumor progression by targeting SOX4 in pediatric osteosarcoma.
Pan L; Meng L; Liang F; Cao L
Mol Med Rep; 2018 Jul; 18(1):441-446. PubMed ID: 29749512
[TBL] [Abstract][Full Text] [Related]
18. lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer.
Jiao C; Song Z; Chen J; Zhong J; Cai W; Tian S; Chen S; Yi Y; Xiao Y
Oncol Rep; 2016 Nov; 36(5):2960-2966. PubMed ID: 27667646
[TBL] [Abstract][Full Text] [Related]
19. Histological and Pathological Assessment of miR-204 and SOX4 Levels in Gastric Cancer Patients.
Yuan X; Wang S; Liu M; Lu Z; Zhan Y; Wang W; Xu AM
Biomed Res Int; 2017; 2017():6894675. PubMed ID: 28133610
[TBL] [Abstract][Full Text] [Related]
20. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
